findmyKOL

Amrita Padda, MD

Basic profile

Rheumatology

ORCIDNPI
RegionToledo, OH · MidwestSpecialtyRheumatologyFocusRheumatology/Immunology
Active KOLfindmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLatest publication2020Online presenceNot yet checkedPayments2021 onwardNIH fundingNot yet indexedWhy? →

Amrita Padda is a Rheumatology/Immunology physician. OpenAlex indexes 6 publications with 412 citations (h-index 6).

Overview

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
6publications

Distinct works indexed by OpenAlex, matched via ORCID.

412citations

Total citations across indexed works.

6h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
18companies · 2021 onward

Companies reporting payments to CMS. Facts, not judgments.

View payments

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

1325 Conference Dr Ste 2010
Toledo, OH 436148009

Telephone

419-383-6644

Provider last certified this registry record 2 Jan 2026.

View the NPPES registry record

Industry payments

18 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:

View the CMS Open Payments record ↗

Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Cancer & immunology

    40.3%
    Folate Analog Metabolic Inhibitor25%
    Methotrexate95%Methotrexate Sodium5%
    Part D<11 patients
    TNF inhibitor6.4%
    Humira(Cf) Pen65%Enbrel Sureclick35%
    Part D<11 patients

    + 5 more classes in this area

  • Antiparasitic

    21.6%
    Antimalarial21.6%
    Hydroxychloroquine Sulfate100%
    Part D89 patients
  • Metabolism & gastrointestinal

    16.8%
    Corticosteroid12%
    Prednisone100%
    Part D58 patients
    Aminosalicylate3.5%
    Sulfasalazine100%
    Part D12 patients

    + 1 more class in this area

Where care is delivered (Part B)0% facility · 100% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

Publications

Matched to this physician's OpenAlex author record; most-cited works shown first.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”